Sitagliptin

Last Updated: 02/24/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 3724 publications

Cost-effectiveness of dual treatment with metformin-sitagliptin versus metformindapagliflozin in patients with type 2 diabetes.

Cost-effectiveness of dual treatment with metformin-sitagliptin versus metformindapagliflozin in patients with type 2 diabetes.

Journal: Gaceta medica de Mexico

Published: December 26, 2025

Comparing area-level patient density and physician prescribing preference instruments for the effect of antidiabetics on adverse cardiovascular events among Medicare beneficiaries.

Comparing area-level patient density and physician prescribing preference instruments for the effect of antidiabetics on adverse cardiovascular events among Medicare beneficiaries.

Journal: Epidemiology (Cambridge, Mass.)

Published: December 15, 2025

Properties of AgNPs stabilized with polyvinylpyrrolidone relevant to antidiabetic agents.

Properties of AgNPs stabilized with polyvinylpyrrolidone relevant to antidiabetic agents.

Journal: Nanoscale

Published: December 10, 2025

Trends in Adverse Event Reports of Dipeptidyl Peptidase-4 Inhibitor-Associated Pemphigoid in Japan.

Trends in Adverse Event Reports of Dipeptidyl Peptidase-4 Inhibitor-Associated Pemphigoid in Japan.

Journal: Drugs - real world outcomes

Published: December 08, 2025

Dual-source DPP4 drives intestinal fibrosis in Crohn's disease: synergistic therapeutic targeting of host and microbiota pathways.

Dual-source DPP4 drives intestinal fibrosis in Crohn's disease: synergistic therapeutic targeting of host and microbiota pathways.

Journal: Gut microbes

Published: December 03, 2025

Sitagliptin does not interfere with VEGF-A signaling in retinal endothelial cells in vitro.

Sitagliptin does not interfere with VEGF-A signaling in retinal endothelial cells in vitro.

Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association

Published: November 25, 2025

Common genetic variants near SLC2A2 and glycemic response to glimepiride in the GRADE comparative effectiveness clinical trial.

Common genetic variants near SLC2A2 and glycemic response to glimepiride in the GRADE comparative effectiveness clinical trial.

Journal: medRxiv : the preprint server for health sciences

Published: November 24, 2025

Addition of sitagliptin to ongoing metformin improved metabolic profile and pancreatic function via normalizing inflammatory cytokines' levels in patients with type 2 diabetes, a randomized double-blinded clinical trial.

Addition of sitagliptin to ongoing metformin improved metabolic profile and pancreatic function via normalizing inflammatory cytokines' levels in patients with type 2 diabetes, a randomized double-blinded clinical trial.

Journal: Expert review of endocrinology & metabolism

Published: November 20, 2025

Dipeptidyl peptidase 4 (DPP-4) inhibitors for people with chronic kidney disease and diabetes.

Dipeptidyl peptidase 4 (DPP-4) inhibitors for people with chronic kidney disease and diabetes.

Journal: The Cochrane database of systematic reviews

Published: November 20, 2025

Noninsulin drugs for type 2 diabetes.

Noninsulin drugs for type 2 diabetes.

Journal: The Medical letter on drugs and therapeutics

Published: November 19, 2025

Comparison chart: Sodium-glucose cotransporter 2 (SGLT2) inhibitors.

Comparison chart: Sodium-glucose cotransporter 2 (SGLT2) inhibitors.

Journal: The Medical letter on drugs and therapeutics

Published: November 19, 2025

Role of sitagliptin in diabetes-induced testicular damage via the Fas/FasL signalling pathway.

Role of sitagliptin in diabetes-induced testicular damage via the Fas/FasL signalling pathway.

Journal: Biotechnic & histochemistry : official publication of the Biological Stain Commission

Published: November 18, 2025

Showing 1-12 of 3,724

Last Updated: 02/24/2026